![Dietmar Berger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dietmar Berger
Directeur Technique/Scientifique/R&D chez
GILEAD SCIENCES, INC.
Fortune : 3 M $ au 31/05/2026
Profil
Dietmar P. Berger occupe le poste de Chief Medical Officer & Global Head-Development chez Sanofi. Au cours de sa carrière, il a occupé les postes de chef mondial de la recherche et du développement chez Atara Biotherapeutics, Inc. et de chef du centre de recherche clinique de l'Universittsklinikum Freiburg, de vice-président de l'hématologie et de l'oncologie cliniques chez Genentech, Inc. et de chef du centre de recherche clinique du Scripps Research Institute. Le Dr Berger a obtenu un diplôme d'études supérieures et un doctorat de l'université de Fribourg.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 19 252 ( 0 % ) | 3 M $ | 31/05/2026 |
Dernières actualités sur Dietmar Berger
Postes actifs de Dietmar Berger
| Sociétés | Poste | Début |
|---|---|---|
| GILEAD SCIENCES, INC. | Directeur Technique/Scientifique/R&D | 02/01/2025 |
| ARCUS BIOSCIENCES, INC. | Directeur/Membre du Conseil | 06/02/2025 |
University of Freiburg
 University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Dietmar Berger
| Sociétés | Poste | Fin |
|---|---|---|
| ATARA BIOTHERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 31/05/2019 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | 01/05/2018 |
| INHIBRX, INC. | President | - |
| SANOFI | Directeur Technique/Scientifique/R&D | - |
The Scripps Research Institute
 The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Formation de Dietmar Berger
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
69
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
University of Freiburg
University of Freiburg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Universitätsklinikum Freiburg
 Universitätsklinikum Freiburg Hospital/Nursing ManagementHealth Services Operates as a teaching hospital | Health Services |
Atara Biotherapeutics, Inc.
 Atara Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Pioneers the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases | Health Technology |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Inhibrx, Inc.
 Inhibrx, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biotechnology company that develops biologic therapeutics for the treatment of cancer | Health Technology |
